Driehaus Capital Management LLC Pacira Bio Sciences, Inc. Transaction History

Driehaus Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $1.9 Million - $2.18 Million	-36,995 Reduced 14.52%	217,752 $11.6 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $4.45 Million - $7.06 Million	-86,453 Reduced 25.34%	254,747 $14.9 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $20.5 Million - $26.1 Million	341,200 New	341,200 $26 Million
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $6.11 Million - $8.02 Million	-121,069 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $6.29 Million - $7.63 Million	121,069 New	121,069 $7.28 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.